收藏切换
Analysis of Gut Microbiota in Patients with Methylmalonic Acidemia and Screening of Propionic Acid Reducing Dietary Factors
收藏切换
Xiaohua SUN1, 2, Hong KUANG1, 2, 3, Zhangming PEI1, 2, Hongchao WANG1, 2, Yahui LI1, 2, 4, Qingwei YAO5, Xudan SHEN5, Xinyi WANG5, Wenwei LU1, 2, 4, *
Science and Technology of Food Industry | 2026, 47(8) : 398 - 406
Less
收藏切换
Science and Technology of Food Industry | 2026, 47(8): 398-406
• Nutrition and Healthcare •
Analysis of Gut Microbiota in Patients with Methylmalonic Acidemia and Screening of Propionic Acid Reducing Dietary Factors
Full
Xiaohua SUN1, 2, Hong KUANG1, 2, 3, Zhangming PEI1, 2, Hongchao WANG1, 2, Yahui LI1, 2, 4, Qingwei YAO5, Xudan SHEN5, Xinyi WANG5, Wenwei LU1, 2, 4, *
Affiliations
  • 1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China
  • 2School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
  • 3Wuxi Life Science Industry Development Co., Ltd., Wuxi 214135, China
  • 4National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214122, China
  • 5Wuxi Special Food and Nutrition Health Research Institute Co., Ltd., Wuxi 214135, China
Published: 2026-04-15 doi: 10.13386/j.issn1002-0306.2025030279
Outline
收藏切换

The intestinal propionic acid level in patients with methylmalonic acidemia (MMA) may affect the course of the disease, but the current intervention strategy is still unclear. This study aimed to elucidate the differences in fecal propionic acid levels and gut microbiota composition between patients with MMA and healthy people, as well as to identify dietary factor combinations that effectively reduce propionic acid production through in vitro fecal fermentation model and MMA rat model. This investigation provides a novel strategy for dietary management in patients with MMA. Gas chromatography-mass spectrometry and metagenomic sequencing were employed to analyze propionic acid content, gut microbiota structure, and species composition in the feces of 28 patients with MMA and 17 healthy people. Subsequently, an in vitro fecal bacterial fermentation model was utilized to screen for optimal combinations among 12 dietary factors capable of significantly reducing propionic acid levels. Finally, 5-day-old Wistar rats (segregated into male and female subgroups) were selected to construct the MMA model and randomly divided into five groups: control group, model group, galactooligosaccharide+arabinogalactan group (GOS+AG group), galactooligosaccharide+tremella polysaccharide group (GOS+TPs group), and arabinogalactan+tremella polysaccharide group (AG+TPs group). Propionic acid content in rat feces was measured and analyzed at three time points: Prior to intervention (14 days), mid-stage (21 days), and late stage (28 days). The results demonstrated significant differences in fecal propionic acid levels (P<0.001) and gut microbiota structure (P=0.003) between patients with MMA and healthy people. Compared to the control group, higher abundances of Blautia wexlerae, Bacteroides thetaiotaomicron, and Blautia producta in the MMA group may represent critical factors influencing changes in intestinal propionic acid levels. After 24 hours of fermentation, screening identified that poria cocos polysaccharides, fructooligosaccharides, galactooligosaccharides, arabinogalactan, and tremella polysaccharides demonstrated significant efficacy in reducing propionic acid levels (P<0.05). Following the combination of the aforementioned five polysaccharides and subsequent fermentation, three combinations with the most effective reduction were identified: GOS+AG group, GOS+TPs group, AG+TPs group (P<0.001). Ultimately, animal experiments confirmed that the combination of AG+TPs group yielded the best results (P<0.0001). In conclusion, differences in fecal propionic acid levels between patients with MMA and healthy people may be associated with variations in gut microbiota composition. The combination of AG+TPs group can effectively reduce propionic acid levels, offering a promising dietary management strategy for patients with MMA.

methylmalonic acidemia  /  propionic acid  /  gut microbiota  /  metagenome  /  dietary polysaccharide
孙晓华, 匡宏, 裴彰明, 王鸿超, 李雅慧, 姚青蔚, 沈旭丹, 王心怡, 陆文伟. 甲基丙二酸血症患者肠道菌群特征解析及靶向降低丙酸水平的膳食多糖筛选. 食品工业科技, 2026 , 47 (8) : 398 -406 . DOI: 10.13386/j.issn1002-0306.2025030279
Xiaohua SUN, Hong KUANG, Zhangming PEI, Hongchao WANG, Yahui LI, Qingwei YAO, Xudan SHEN, Xinyi WANG, Wenwei LU. Analysis of Gut Microbiota in Patients with Methylmalonic Acidemia and Screening of Propionic Acid Reducing Dietary Factors[J]. Science and Technology of Food Industry, 2026 , 47 (8) : 398 -406 . DOI: 10.13386/j.issn1002-0306.2025030279
Year 2026 volume 47 Issue 8
116
61
Cite this Article
BibTeX
Article Info
doi: 10.13386/j.issn1002-0306.2025030279
  • Receive Date:2025-03-20
  • Online Date:2026-10-24
  • Published:2026-04-15
Article Data
Affiliations
History
  • Received:2025-03-20
Affiliations
    1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China
    2School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
    3Wuxi Life Science Industry Development Co., Ltd., Wuxi 214135, China
    4National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214122, China
    5Wuxi Special Food and Nutrition Health Research Institute Co., Ltd., Wuxi 214135, China
References
Share
https://castjournals.cast.org.cn/joweb/spgykj/EN/10.13386/j.issn1002-0306.2025030279
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT